IShares Pharmaceuticals Etf Forecast - Price Action Indicator
| IHE Etf | USD 68.39 0.33 0.48% |
IShares Etf Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast IShares Pharmaceuticals stock prices and determine the direction of iShares Pharmaceuticals ETF's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of IShares Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
IShares |
| Previous Price Action Indicator | Price Action Indicator | Trend |
| 0.045 | 0.23 |
| Check IShares Pharmaceuticals Volatility | Backtest IShares Pharmaceuticals | Information Ratio |
IShares Pharmaceuticals Trading Date Momentum
| On November 23 2024 iShares Pharmaceuticals ETF was traded for 68.39 at the closing time. Highest IShares Pharmaceuticals's price during the trading hours was 68.43 and the lowest price during the day was 68.22 . There was no trading activity during the period 0.0. Lack of trading volume on the 23rd of November had no short-term effect on price fluctuation. The trading date delta to current price is 0.06% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare IShares Pharmaceuticals to competition |
Other Forecasting Options for IShares Pharmaceuticals
For every potential investor in IShares, whether a beginner or expert, IShares Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. IShares Etf price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in IShares. Basic forecasting techniques help filter out the noise by identifying IShares Pharmaceuticals' price trends.IShares Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with IShares Pharmaceuticals etf to make a market-neutral strategy. Peer analysis of IShares Pharmaceuticals could also be used in its relative valuation, which is a method of valuing IShares Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
iShares Pharmaceuticals Technical and Predictive Analytics
The etf market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of IShares Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of IShares Pharmaceuticals' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
IShares Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how IShares Pharmaceuticals etf reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading IShares Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying IShares Pharmaceuticals etf market strength indicators, traders can identify iShares Pharmaceuticals ETF entry and exit signals to maximize returns.
IShares Pharmaceuticals Risk Indicators
The analysis of IShares Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in IShares Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting ishares etf prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 0.5756 | |||
| Standard Deviation | 0.7224 | |||
| Variance | 0.5219 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether iShares Pharmaceuticals is a strong investment it is important to analyze IShares Pharmaceuticals' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact IShares Pharmaceuticals' future performance. For an informed investment choice regarding IShares Etf, refer to the following important reports:Check out Historical Fundamental Analysis of IShares Pharmaceuticals to cross-verify your projections. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
The market value of iShares Pharmaceuticals is measured differently than its book value, which is the value of IShares that is recorded on the company's balance sheet. Investors also form their own opinion of IShares Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is IShares Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because IShares Pharmaceuticals' market value can be influenced by many factors that don't directly affect IShares Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between IShares Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if IShares Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, IShares Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.